Answer to Question #258168 in English for Jen

Question

Concerning heart disease what are the costs verses the benefits of early intervention? Should all children be routinely screened for heart disease? What are the implications for screening and for not screening? Would you as a parent want to know if your child is at risk for developing heart disease? How has COVID 19 changed medical screening needs especially with athletes and their cardiovascular system? Write a paragraph

Answer 1

Early Intervention is a program of medically supervised exercise, group education and individual counseling to encourage lifestyle changes to reduce the risk of heart disease and enhance health and well-being. Early intervention will also provide great value in developing a healthier, more productive society. Heart disease can be fatal, but they can also lead to serious illness, disability, and lower quality of life. Following a heart attack, individuals frequently suffer fatigue and depression, and they may find it more difficult to engage in physical activities.

Screening is recommended among children with a family history of high cholesterol or a family history of premature heart disease. Screening is also recommended for kids who are overweight (at or above the 85th percentile), who smoke, or who have diabetes or high blood pressure.

An effective screening test may decrease your chances of dying of the condition. A health screening helps you find out if you have a particular disease or condition. Sometimes, you may not show any signs of symptoms or disease. Early detection, followed by treatment and control of the condition can result in good outcome and lowers the risk of serious complications. When one is not screened, they will not be able to know particular diseases or conditions they are suffering from. However, every screening test comes with its own risks. Some procedures can cause problems like bleeding or infection.

As a parent I would be interested to know if my child is at risk for developing heart disease. If the child has a congenital heart defect, it means that he or she was born with a problem in the structure of his or her heart. Some congenital heart defects in children are simple and don't need treatment. Other congenital heart defects in children are more complex and may require several surgeries performed over a period of several years. Learning about your child's congenital heart defect can help you understand the condition and know what you can expect in the coming months and years. Family history may also make a parent want to know if their children are at the risk of developing heart disease. Children of parents with heart disease are more likely to develop it themselves. Most people with a strong family history of heart disease have one or more other risk factors, increasing the importance of treating and controlling any other risk factors.

As complications of coronavirus disease-2019 (COVID-19) evolve, subclinical cardiac pathology such as myocarditis, pericarditis, and right ventricular dysfunction in the absence of significant clinical symptoms represents a concern. The potential implications of these findings in athletes are significant given the concern that exercise, during the acute phase of viral myocarditis, may exacerbate myocardial injury and precipitate malignant ventricular arrhythmias. Athletes recovering from COVID-19 present some unique challenges. There is concern that exercise during the acute phase of viral myocarditis may exacerbate or prolong the illness or serve as a trigger for serious arrhythmias. Many athletes may be asymptomatic or experience nonspecific symptoms that they do not recognize as being associated with COVID-19 and will remain entirely asymptomatic at the time of RTP evaluation. Other athletes may have nonspecific malaise, reduced exercise tolerance, recurrent chest pain, dyspnea, or palpitations at the time of illness, which may persist into convalescence. The evaluation of athletes with persistent symptoms after recovery from acute COVID-19 will be guided by the nature of the symptoms, whereas the evaluation of the asymptomatic athlete will be oriented around screening for subclinical pathology.